AAAAAA

   
Results: 1-17 |
Results: 17
Forearm blood flow and local responses to peptide vasodilators: A novel pharmacodynamic measure in the phase I trial of antagonist G, a neuropeptide growth factor antagonist
Authors: Clive, S Webb, DJ MacLellan, A Young, A Byrne, B Robson, L Smyth, JF Jodrell, DI
Citation: S. Clive et al., Forearm blood flow and local responses to peptide vasodilators: A novel pharmacodynamic measure in the phase I trial of antagonist G, a neuropeptide growth factor antagonist, CLIN CANC R, 7(10), 2001, pp. 3071-3078
Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group Report
Authors: Coudert, B Anthoney, A Fiedler, W Droz, JP Dieras, V Borner, M Smyth, JF Morant, R de Vries, MJ Roelvink, M Fumoleau, P
Citation: B. Coudert et al., Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group Report, EUR J CANC, 37(17), 2001, pp. 2194-2198
Science and serendipity in cancer research
Authors: Smyth, JF
Citation: Jf. Smyth, Science and serendipity in cancer research, EUR J CANC, 37(1), 2001, pp. 8-8
Effective dosing of topotecan with carboplatin in relapsed ovarian cancer:A phase I/II study
Authors: Bowman, A Rye, T Ross, G Wheatley, A Smyth, JF
Citation: A. Bowman et al., Effective dosing of topotecan with carboplatin in relapsed ovarian cancer:A phase I/II study, J CL ONCOL, 19(13), 2001, pp. 3255-3259
WWOX: A candidate tumor suppressor gene involved in multiple tumor types
Authors: Paige, AJW Taylor, KJ Taylor, C Hillier, SG Farrington, S Scott, D Porteous, DJ Smyth, JF Gabra, G Watson, JEV
Citation: Ajw. Paige et al., WWOX: A candidate tumor suppressor gene involved in multiple tumor types, P NAS US, 98(20), 2001, pp. 11417-11422
Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancer
Authors: Gilmour, LMR Macleod, KG McCaig, A Gullick, WJ Smyth, JF Langdon, SP
Citation: Lmr. Gilmour et al., Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancer, CANCER RES, 61(5), 2001, pp. 2169-2176
BARX2 induces cadherin 6 expression and is a functional suppressor of ovarian cancer progression
Authors: Sellar, GC Li, L Watt, KP Nelkin, BD Rabiasz, GJ Stronach, EA Miller, EP Porteous, DJ Smyth, JF Gabra, H
Citation: Gc. Sellar et al., BARX2 induces cadherin 6 expression and is a functional suppressor of ovarian cancer progression, CANCER RES, 61(19), 2001, pp. 6977-6981
A prognostic model for ovarian cancer
Authors: Clark, TG Stewart, ME Altman, DG Gabra, H Smyth, JF
Citation: Tg. Clark et al., A prognostic model for ovarian cancer, BR J CANC, 85(7), 2001, pp. 944-952
Adjuvant interferon alpha 2b in high risk melanoma - the Scottish study
Authors: Cameron, DA Cornbleet, MC Mackie, RM Hunter, JAA Gore, M Hancock, B Smyth, JF
Citation: Da. Cameron et al., Adjuvant interferon alpha 2b in high risk melanoma - the Scottish study, BR J CANC, 84(9), 2001, pp. 1146-1149
High-performance liquid chromatographic technique for the simultaneous determination of lactone and hydroxy acid forms of camptothecin and SN-38 in tissue culture media and cancer cells
Authors: Boyd, G Smyth, JF Jodrell, DI Cummings, J
Citation: G. Boyd et al., High-performance liquid chromatographic technique for the simultaneous determination of lactone and hydroxy acid forms of camptothecin and SN-38 in tissue culture media and cancer cells, ANALYT BIOC, 297(1), 2001, pp. 15-24
A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D
Authors: Paige, AJW Taylor, KJ Stewart, A Sgouros, JG Gabra, H Sellar, GC Smyth, JF Porteous, DJ Watson, JEV
Citation: Ajw. Paige et al., A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D, CANCER RES, 60(6), 2000, pp. 1690-1697
Identification and characterization of a homozygous deletion found in ovarian ascites by representational difference analysis
Authors: Watson, JEV Gabra, H Taylor, KJ Rabiasz, GJ Morrison, H Perry, P Smyth, JF Porteous, DJ
Citation: Jev. Watson et al., Identification and characterization of a homozygous deletion found in ovarian ascites by representational difference analysis, GENOME RES, 9(3), 1999, pp. 226-233
Paracrine regulation of ovarian cancer by endothelin
Authors: Moraitis, S Miller, WR Smyth, JF Langdon, SP
Citation: S. Moraitis et al., Paracrine regulation of ovarian cancer by endothelin, EUR J CANC, 35(9), 1999, pp. 1381-1387
Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer
Authors: Connolly, KC Gabra, H Millwater, CJ Taylor, KJ Rabiasz, GJ Watson, JEV Smyth, JF Wyllie, AH Jodrell, DI
Citation: Kc. Connolly et al., Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer, CANCER RES, 59(12), 1999, pp. 2806-2809
[Arg(6),D-Trp(7,9),N(me)Phe(8)]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism
Authors: MacKinnon, AC Armstrong, RA Waters, CM Cummings, J Smyth, JF Haslett, C Sethi, T
Citation: Ac. Mackinnon et al., [Arg(6),D-Trp(7,9),N(me)Phe(8)]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism, BR J CANC, 80(7), 1999, pp. 1026-1034
Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines
Authors: Wilson, KE Bartlett, JMS Miller, EP Smyth, JF Mullen, P Miller, WR Langdon, SP
Citation: Ke. Wilson et al., Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines, BR J CANC, 80(5-6), 1999, pp. 685-692
Growth factors and ovarian cancer
Authors: Langdon, SP Smyth, JF
Citation: Sp. Langdon et Jf. Smyth, Growth factors and ovarian cancer, ENDOCR-R CA, 5(4), 1998, pp. 283-291
Risultati: 1-17 |